Specialized Medical Company vs Dallah Healthcare Co.
A head-to-head of Specialized Medical Company (4019) and Dallah Healthcare Co. (4004) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 4019 | 4004 |
|---|---|---|
| Market Cap | 4.18B SAR | 10.78B SAR |
| P/E (TTM) | 15.09 | 20.02 |
| Forward P/E | 15.21 | 20.80 |
| P/S | 2.70 | 2.67 |
| P/B | 3.93 | 2.64 |
| EV/EBITDA | 16.36 | 20.79 |
| Dividend Yield | 1.91% | 1.79% |
| Profit Margin | 17.36% | 11.15% |
| Gross Margin | 24.89% | 35.71% |
| Operating Margin | 15.82% | 15.40% |
| Revenue Growth (YoY) | +3.19% | +21.68% |
| FCF Yield | 4.78% | -0.21% |
| Debt / Equity | 52.90 | 94.09 |
| Current Ratio | 1.10 | 1.20 |
Which is better: Specialized Medical Company or Dallah Healthcare Co.?
- ✓Larger by market cap: Dallah Healthcare Co.
- ✓Cheaper valuation (lower P/E): Specialized Medical Company
- ✓Higher dividend yield: Specialized Medical Company
- ✓More profitable (net margin): Specialized Medical Company
- ✓Faster revenue growth: Dallah Healthcare Co.
- ✓Higher free-cash-flow yield: Specialized Medical Company
Across 13 available metrics, Specialized Medical Company leads 8–5.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Specialized Medical Company with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.